Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017

por Charre, Caroline, Ramière, Christophe, Roque-Afonso, Anne-Marie, Chidiac, Christian, Zoulim, Fabien, Godinot, Matthieu, Koffi, Joseph, Scholtès, Caroline, Livrozet, Jean-Michel, Cotte, Laurent
Publicado 2017

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

por Hatu, Giorgiana, Bailly, François, Pourcelot, Emmanuel, Pradat, Pierre, Miailhes, Patrick, Maynard, Marianne, Parant, François, Chiarello, Pierre, Livrozet, Jean-Michel, Zoulim, Fabien, Gagnieu, Marie-Claude
Publicado 2014

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

por Eron, Joseph J., Clotet, Bonaventura, Durant, Jacques, Katlama, Christine, Kumar, Princy, Lazzarin, Adriano, Poizot-Martin, Isabelle, Richmond, Gary, Soriano, Vincent, Ait-Khaled, Mounir, Fujiwara, Tamio, Huang, Jenny, Min, Sherene, Vavro, Cindy, Yeo, Jane, Walmsley, Sharon L., Cox, Joseph, Reynes, Jacques, Morlat, Philippe, Vittecoq, Daniel, Livrozet, Jean-Michel, Fernández, Pompeyo Viciana, Gatell, Jose M., DeJesus, Edwin, DeVente, Jerome, Lalezari, Jacob P., McCurdy, Lewis H., Sloan, Louis A., Young, Benjamin, LaMarca, Anthony, Hawkins, Trevor
Publicado 2013